Chiba University School of Medical

Greetings from Dean

K20PD-0074C_USB - ホームページ.jpg
Hisahiro Matsubara,
M.D., Ph.D.

Towards the development of a “World-class Medical Research and Education Hub”

Welcome to the Graduate School of Medicine

There are two fields of medicine: “basic medicine” and “clinical medicine.” With more than 100 years of history, Chiba University’s Graduate School of Medicine and School of Medicine now focuses on the promotion of research in “Innovative Therapeutics (Chiryougaku in Japanese),“ a new field that connects those two fields of medicine and seeks to cultivate “Physician-scientists” and “Medical researchers.” A physician-scientist is someone who pursues research in “Therapeutics” and connects the results of state-of-the-art basic research to the development of new therapies to improve the QOL of patients and/or to cure refractory disease.

While enrolled in the School of Medicine, students may participate in the "Scholarship Program,” and several"Student Exchange Program." Through their involvement in discussions and activities, regardless of age, professional field, school or nationality, students are able to learn more than medical knowledge and skills. They can learn the significance of research in basic, clinical and social medicine, collect the scientific information necessary to plan and implement a research project and engage in logical and critical thinking.

The Graduate School of Medicine offers the "CHIBA Innovation Program for Therapeutics (CIPT)" and the "Leading Graduate School Program (LGS) " with the goal of developing future leaders in Therapeutics, specifically in the treatment of immune-related diseases, such as cancer, allergies and arteriosclerosis.

Students will be exposed to a wider view for the future of medicine and options through our unique education to promote vertical and horizontal coordination. We hope to make a social contribution to the fields of medicine and health care by producing the best minds capable of meeting the needs of our diverse society.